Combination Immunotherapy Efficacy in Lung Cancer May Differ by Patient Sex

Leggi l'articolo originale


A study in the Journal of the National Cancer Institute evaluated responses in men vs women to combination chemotherapy and a PD-1 or PD-L1 inhibitor.

Lascia un commento